Cyclooxygenase-2 blockade can improve efficacy of VEGF-targeting drugs

Anti-angiogenic therapies were approved for different cancers. However, significant primary and secondary resistance hampers efficacy in several tumor types including breast cancer. Thus, we need to develop clinically applicable strategies to enhance efficacy of anti-angiogenic drugs. We report that...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncotarget
Egile Nagusiak: Ben-Batalla, Isabel, Cubas-Cordova, Miguel, Udonta, Florian, Wroblewski, Mark, Waizenegger, Jonas S., Janning, Melanie, Sawall, Stefanie, Gensch, Victoria, Zhao, Lin, Martinez-Zubiaurre, Iñigo, Riecken, Kristoffer, Fehse, Boris, Pantel, Klaus, Bokemeyer, Carsten, Loges, Sonja
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Impact Journals LLC 2015
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4467441/
https://ncbi.nlm.nih.gov/pubmed/25849942
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak